Trials / Terminated
TerminatedNCT02030548
Bleeding in Patients Undergoing CABG (Coronary Artery Bypass Graft) During Dual Antiplatelet Therapy
Bleeding in Patients Undergoing Urgent CABG During Dual Antiplatelet Therapy Including the New P2Y12 Receptor Inhibitors Prasugrel and Ticagrelor
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 144 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate surgery-related bleeding and mortality in patients needing acute coronary artery bypass grafting with or without valve replacement during dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker (Clopidogrel, Prasugrel, Ticagrelor)
Conditions
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2014-01-08
- Last updated
- 2019-06-06
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02030548. Inclusion in this directory is not an endorsement.